tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IRD Stock Latest News

Opus Genetics: Strategic Collaborations and Promising Trial Outcomes Justify Buy Rating
RatingsOpus Genetics: Strategic Collaborations and Promising Trial Outcomes Justify Buy Rating
7d ago
IRD
Opus Genetics: Promising Developments and Strong Pipeline Justify Buy Rating
PremiumRatings
Opus Genetics: Promising Developments and Strong Pipeline Justify Buy Rating
8d ago
IRD
Opus Genetics Announces Positive Phase 3 Trial Results
PremiumCompany Announcements
Opus Genetics Announces Positive Phase 3 Trial Results
8d ago
8K
IRD
Opus Genetics’ Phentolamine Ophthalmic Solution meets primary Phase 3 endpoint
PremiumThe Fly
Opus Genetics’ Phentolamine Ophthalmic Solution meets primary Phase 3 endpoint
8d ago
IRD
Opus Genetics Secures $2M Funding for Gene Therapy
PremiumCompany Announcements
Opus Genetics Secures $2M Funding for Gene Therapy
11d ago
8K
IRD
Opus Genetics awarded non-dilutive funding from the RD Fund
PremiumThe FlyOpus Genetics awarded non-dilutive funding from the RD Fund
11d ago
IRD
Opus Genetics Secures Funding for MERTK Program
Premium
Company Announcements
Opus Genetics Secures Funding for MERTK Program
14d ago
8K
IRD
Opus Genetics initiated with a Buy at Lucid Capital
Premium
The Fly
Opus Genetics initiated with a Buy at Lucid Capital
17d ago
IRD
Opus Genetics’ Ryzumvi Shows Promising Phase 3 Results, Reinforcing Buy Rating
PremiumRatings
Opus Genetics’ Ryzumvi Shows Promising Phase 3 Results, Reinforcing Buy Rating
1M ago
IRD
Opus Genetics says LYNX-2 trial met primary endpoint
PremiumThe Fly
Opus Genetics says LYNX-2 trial met primary endpoint
1M ago
IRD
Opus Genetics’ Promising Gene Therapy Advances and Strategic Partnerships Reinforce Buy Rating
PremiumRatings
Opus Genetics’ Promising Gene Therapy Advances and Strategic Partnerships Reinforce Buy Rating
2M ago
IRD
Opus Genetics reports Q1 EPS (24c) vs (29c) last year
PremiumThe Fly
Opus Genetics reports Q1 EPS (24c) vs (29c) last year
2M ago
IRD
Opus Genetics announces upcoming presentations
PremiumThe FlyOpus Genetics announces upcoming presentations
2M ago
IRD
Opus Genetics announces U.S. FDA granted RMAT designation to OPGx-LCA5
Premium
The Fly
Opus Genetics announces U.S. FDA granted RMAT designation to OPGx-LCA5
2M ago
IRD
Opus Genetics announces one-year results on OPGx-LCA5
Premium
The Fly
Opus Genetics announces one-year results on OPGx-LCA5
2M ago
IRD
Craig-Hallum bullish on Opus Genetics, initiates with a Buy
PremiumThe Fly
Craig-Hallum bullish on Opus Genetics, initiates with a Buy
3M ago
IRD
Opus Genetics initiated with a Buy at Craig-Hallum
PremiumThe Fly
Opus Genetics initiated with a Buy at Craig-Hallum
3M ago
IRD
Opus Genetics announces data from patient in Phase 1/2 trial of OPGx-LCA5
PremiumThe Fly
Opus Genetics announces data from patient in Phase 1/2 trial of OPGx-LCA5
3M ago
IRD
Opus Genetics urges stockholders to vote for company’s nine board nominees
PremiumThe Fly
Opus Genetics urges stockholders to vote for company’s nine board nominees
3M ago
IRD
Opus Genetics Terminates Purchase Agreement with Lincoln Park
PremiumCompany AnnouncementsOpus Genetics Terminates Purchase Agreement with Lincoln Park
3M ago
8K
IRD
Opus Genetics price target lowered to $8 from $9 at JonesResearch
Premium
The Fly
Opus Genetics price target lowered to $8 from $9 at JonesResearch
3M ago
IRD
Opus Genetics: Strategic Advances in AAV-Based Gene Therapies and Key Catalysts for Growth
Premium
Ratings
Opus Genetics: Strategic Advances in AAV-Based Gene Therapies and Key Catalysts for Growth
3M ago
IRD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >